Second Primary Malignancy Incidence in Patients Receiving Lenalidomide at Induction and Maintenance; Long-Term Follow up of 4358 Patients Enrolled to the Myeloma XI Trial

Authors :: John R Jones
David Cairns
Tom Menzies
Charlotte Pawlyn
Faith E. Davies
Rachel Sigsworth
Matthew W Jenner
Martin F. Kaiser
Rebecca Mottram
Mark T Drayson
Walter Martin Gregory
Roger G Owen
Kevin Boyd
Gordon Cook
Graham Jackson
Gareth J. Morgan
Source :: Blood. 140:1823-1825
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools